Advent Life Sciences Growth Fund LP — Form D/A
Advent Life Sciences Growth Fund LP of LONDON, X0, a pooled investment fund, filed a Form D amendment with the SEC on 2025-11-07. $9.8M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-11-07
- Form: D/A
- Accession: 0002040586-25-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Amount sold: $9.8M
- Investors: 1
- Date of first sale: 2024-10-14
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-527005
Issuer
- Name: Advent Life Sciences Growth Fund LP
- CIK: 0002040586
- Entity type: Limited Partnership
- Jurisdiction: UNITED KINGDOM
- Incorporated: 2023
- Address: 27 FITZROY SQUARE, LONDON, X0, W1T 6ES
- Phone: 44 020 7932 2120
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| - Advent Life Sciences LLP | Executive Officer | London, X0 |
| Kaasim Mahmood | Executive Officer | London, X0 |
| Shahzad Malik | Executive Officer | San Diego, CA |
| Rajesh Parekh | Executive Officer | London, X0 |
| Dominic Schmidt | Executive Officer | London, X0 |
| - Advent Life Sciences LLP | Promoter | London, X0 |
| Dominic Schmidt | Promoter | London, X0 |
Other filings by this issuer (1)
More